Lek to build US$400m biosimilars production facility in Lendava
Ljubljana, 9 March - The government and pharmaceutical company Lek, which is part of the Swiss group Sandoz, signed a memorandum of understanding for Lek's high-tech biosimilars production facility to be built in the town of Lendava as Prime Minster Robert Golob and Economy Minister Matjaž Han met with Lek and Sandoz senior executives on Thursday.
Ljubljana
A meeting at the Presidential Palace between PM Robert Golob and Economy Minister Matjaž Han, and Sandoz CEO Richard Saynor and Lek CEO and Sandoz Slovenija president Robert Ljolj.
Photo: Nebojša Tejić/STA
Ljubljana
A meeting at the Presidential Palace between PM Robert Golob and Economy Minister Matjaž Han, and Sandoz CEO Richard Saynor and Lek CEO and Sandoz Slovenija president Robert Ljolj.
Photo: Nebojša Tejić/STA
Ljubljana
A meeting at the Presidential Palace between PM Robert Golob and Economy Minister Matjaž Han, and Sandoz CEO Richard Saynor and Lek CEO and Sandoz Slovenija president Robert Ljolj.
Photo: Nebojša Tejić/STA
Ljubljana
The seat of the pharma company Lek.
Photo: Bor Slana/STA
File photo
Ljubljana
The logo of Lek.
Photo: Daniel Novakovič/STA
File photo
The rest of this news item is available to subscribers.
The news item consists of 421 characters (without spaces) or 84 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.